Drug Shortage Report for ACT ESCITALOPRAM ODT
| Report ID | 157265 |
| Drug Identification Number | 02454300 |
| Brand name | ACT ESCITALOPRAM ODT |
| Common or Proper name | ESCITALOPRAM 20MG OD TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ESCITALOPRAM |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL ORAL |
| Packaging size | 30UD |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-03-20 |
| Estimated end date | 2022-04-20 |
| Actual end date | 2022-05-04 |
| Shortage status | Resolved |
| Updated date | 2022-05-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-05-05 | French | Compare |
| v5 | 2022-05-05 | English | Compare |
| v4 | 2022-03-31 | French | Compare |
| v3 | 2022-03-31 | English | Compare |
| v2 | 2022-03-24 | French | Compare |
| v1 | 2022-03-24 | English | Compare |
Showing 1 to 6 of 6